Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hormone therapy for trans individuals is effective and generally safe in the short term.

A woman developed male characteristics after using unregulated hormone therapy.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Estrogen alone can lower testosterone in some transfeminine people.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Many transgender men on testosterone therapy experience hair loss.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Menopausal hormone therapy can improve skin and hair health in menopausal women.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

New treatments for male hypogonadism are effective and should be personalized.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.